Gutting of FDA’s generic drug policy office will raise prices
President Trump often touted during his first term that his administration had “approved more affordable generic drugs than…
Civica says study ‘validates’ its model for selling low-cost generics
Five years after launching, a unique nonprofit drug company has published data showing that consumers and health plans…